You must be aged 21 or older to visit the website.
Flora has signed a letter of intent to acquire a 100% interest in Cronomed.
Cronomed manufactures and distributes a large portfolio of pharmaceutical drugs registered & licenced with INVIMA (FDA-equivalent), including:
Cronomed also has 52 other brands that will provide high-margin sales immediately from a traditional line that does not include cannabis.
Flora will work with Cronomed’s R&D team to expand the line of medicines, phytotherapeutic products and cosmetics to include CBD.
Key asset to be utilized for production of Flora’s medical-grade cannabis drugs and consumer products
Cronomed provides Flora a unique and proven baseline already-revenue-generating drug manufacturing and distribution business.
Sample of the 37 drugs registered and being manufactured and distributed by Cronomed:
Notes: Images represent actual products manufactured and distributed by Cronomed.
Interested in participating?
Be a part of our exciting future and participate in our Reg A+ offering.